Literature DB >> 31903292

The added value of quantitative 18F-FDG-PET/CT parameters in the assessment of pulmonary lymphangitic carcinomatosis in lung cancer.

Dexter P Mendoza1, Subba R Digumarthy1.   

Abstract

Entities:  

Year:  2019        PMID： 31903292      PMCID： PMC6940241          DOI： 10.21037/jtd.2019.10.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  Pulmonary lymphangitic carcinomatosis: diagnostic performance of HRCT and 18F-FDG-PET/CT in correlation to clinical pathologic outcome.

Authors:  Mario Jreige; Vincent Dunet; Igor Letovanec; John O Prior; Reto A Meuli; Catherine Beigelman-Aubry; Niklaus Schaefer
Journal:  J Nucl Med       Date:  2019-06-21       Impact factor: 10.057

2.  Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification.

Authors:  M L Janower; J B Blennerhassett
Journal:  Radiology       Date:  1971-11       Impact factor: 11.105

3.  Pulmonary lymphangitic carcinomatosis: CT and pathologic findings.

Authors:  P L Munk; N L Müller; R R Miller; D N Ostrow
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

4.  Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.

Authors:  Dexter P Mendoza; Justin Stowell; Alona Muzikansky; Jo-Anne O Shepard; Alice T Shaw; Subba R Digumarthy
Journal:  Clin Lung Cancer       Date:  2019-05-11       Impact factor: 4.785

5.  Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis.

Authors:  R G Masson; J Krikorian; P Lukl; G L Evans; J McGrath
Journal:  N Engl J Med       Date:  1989-07-13       Impact factor: 91.245

6.  Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium?

Authors:  O Honda; T Johkoh; K Ichikado; S Yoshida; N Mihara; M Higashi; N Tomiyama; M Maeda; S Hamada; H Naito; N Takeuchi; S Yamamoto; H Nakamura
Journal:  J Comput Assist Tomogr       Date:  1999 May-Jun       Impact factor: 1.826

7.  Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis.

Authors:  Subba R Digumarthy; Alan J Fischman; Boon Han Kwek; Suzanne L Aquino
Journal:  J Comput Assist Tomogr       Date:  2005 May-Jun       Impact factor: 1.826

8.  Pulmonary tumor embolism to arterial vessels and carcinomatous lymphangitis. A comparative clinicopathological study.

Authors:  F A Soares; A P Pinto; G A Landell; J A de Oliveira
Journal:  Arch Pathol Lab Med       Date:  1993-08       Impact factor: 5.534

9.  Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors.

Authors:  J Ikezoe; J D Godwin; K J Hunt; S I Marglin
Journal:  AJR Am J Roentgenol       Date:  1995-07       Impact factor: 3.959

10.  Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?

Authors:  Subba R Digumarthy; Atul M Padole; Roberto Lo Gullo; Lecia V Sequist; Mannudeep K Kalra
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889
View more
  2 in total

1.  The Association Between Lung Fluorodeoxyglucose Metabolism and Smoking History in 347 Healthy Adults.

Authors:  Liang-Qian Tong; Yan-Fang Sui; Sheng-Nan Jiang; Yan-Hai Yin
Journal:  J Asthma Allergy       Date:  2021-03-31

2.  Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of 18F-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography in Colorectal Cancer.

Authors:  Yi-Xin Yin; Ming-Zhi Xie; Xin-Qiang Liang; Meng-Ling Ye; Ji-Lin Li; Bang-Li Hu
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.